Dr Reddys Laboratories RDY
NYSE RDY
$11.88 +0.00 (+0.00%)
As of: Sep 9, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Acquisitions (2015 - 2026)

Dr Reddys Laboratories (RDY) posted Acquisitions of -$2.3 million for Q2 2026, up 66.97% on a QoQ basis from -$7.0 million in Q3 2020.

Analysis

Dr Reddys Laboratories (RDY) Acquisitions (2015 - 2026) Analysis & Trends

Dr Reddys Laboratories has reported Acquisitions for 3 years, with the latest figure at -$2.3 million in Q2 2026.

  • On a quarterly basis, Acquisitions changed N/A year-over-year to -$2.3 million in Q2 2026; TTM through Jun 2026 was -$9.4 million, a N/A change from a year earlier, with the FY2026 full-year figure at -$34.0 million, up 94.53% from the prior year.
  • Acquisitions was -$2.3 million for Q2 2026 at Dr Reddys Laboratories, up from -$7.0 million in the prior quarter.
  • The five-year high for Acquisitions was -$2.3 million in Q2 2026, with the low at -$2.3 million in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn -
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn -2.32 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn -
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn -
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.32 Mn
Sep 30, 2020 -7.04 Mn
Jun 30, 2020 -197.13 Mn
Jun 30, 2015 -125.31 Mn